HIMS vs OMCL
HIMS: A consumer-first digital health platform connecting patients to licensed providers for prescription medications and wellness services across sexual health, weight loss, hair loss, and mental health via telehealth consultations. OMCL: Omnicell empowers hospitals and health systems with automated medication management and intelligence solutions to drive clinical, operational, and financial efficiency.
Side-by-side fundamentals
| Metric | HIMS | OMCL | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $30.24 | $35.37 | |
| Market cap as of 2026-08-03 | $6.4B | $1.6B | |
| P/E as of 2026-08-03 | 50.07 | 41.82 | OMCL lower |
| PEG as of 2026-08-03 | n/a | 2.97 | |
| Net margin as of 2026-08-03 | -0.6% | +3.1% | OMCL higher |
| Gross margin as of 2026-08-03 | +72.9% | +44.8% | HIMS higher |
| Operating margin as of 2026-08-03 | -1.3% | +4.7% | OMCL higher |
| ROE as of 2026-08-03 | -2.5% | +3.1% | OMCL higher |
| ROA as of 2026-08-03 | -0.6% | +2.0% | OMCL higher |
| Debt / equity as of 2026-08-03 | 2.18 | 0.13 | OMCL lower |
| Revenue growth (YoY) as of 2026-08-03 | +32.8% | +8.4% | HIMS higher |
| Revenue CAGR (3y) SEC XBRL | +64.5% | -2.9% | HIMS higher |
| Beta as of 2026-08-03 | 2.44 | 0.81 | |
| 1-year return as of 2026-07-27 close | -47.5% | +14.1% | OMCL higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.